KR Choksey is bullish on Zydus Lifesciences has recommended buy rating on the stock with a target price of Rs 1201 in its ...

Quarterly Net Profit at Rs. 0.76 crore in December 2024 down 76.04% from Rs. 3.17 crore in December 2023. EBITDA stands at Rs ...

Net Sales at Rs 411.79 crore in December 2024 up 13.02% from Rs. 364.35 crore in December 2023. Quarterly Net Profit at Rs.

Quarterly Net Profit at Rs. 47.67 crore in December 2024 up 2578.09% from Rs. 1.78 crore in December 2023. EBITDA stands at ...

Net Sales at Rs 61.21 crore in December 2024 down 19.47% from Rs. 76.01 crore in December 2023. Quarterly Net Profit at Rs. 0 ...

Quarterly Net Profit at Rs. 23.10 crore in December 2024 up 9.53% from Rs. 21.09 crore in December 2023. EBITDA stands at Rs.

Quarterly Net Profit at Rs. 557.13 crore in December 2024 up 3.49% from Rs. 538.36 crore in December 2023. EBITDA stands at ...

Quarterly Net Profit at Rs. 7.81 crore in December 2024 down 51.04% from Rs. 15.95 crore in December 2023. EBITDA stands at ...

Net Sales at Rs 648.61 crore in December 2024 up 7.88% from Rs. 601.22 crore in December 2023. Quarterly Net Loss at Rs.

Net Sales at Rs 36.96 crore in December 2024 up 17.61% from Rs. 31.42 crore in December 2023. Quarterly Net Profit at Rs.

Quarterly Net Profit at Rs. 1.00 crore in December 2024 up 918.37% from Rs. 0.10 crore in December 2023. EBITDA stands at Rs.

Quarterly Net Profit at Rs. 37.34 crore in December 2024 up 123.38% from Rs. 16.71 crore in December 2023. EBITDA stands at ...